Sciensus achieves 95% patient satisfaction and record NPS

At Sciensus, delivering life-changing therapies is more than a service — it’s a commitment to the people behind every prescription. In our latest annual Patient Satisfaction Survey, an overwhelming 95% of respondents reported being satisfied with the support and services we provide — a testament to the dedication of our clinical, nursing, logistics and digital care teams across Europe. 

This year’s Net Promoter Score (NPS) of 64, up from 57 in 2024, reflects a consistent and growing confidence in the way we care for patients and our commitment to continuous improvement. It confirms our belief that putting patients at the centre of every decision drives better experiences, stronger outcomes and greater impact for the life sciences partners we support. 

Commitment reinforced by innovation 

Our digital solutions continue to enhance the patient’s experience, with tools that help people manage their treatment journey, communicate with their care teams, and feel empowered in their own health. This integration of technology and human care ensures patients remain informed, engaged and supported every step of the way. 

A powerful signal to our partners 

These results not only reflect patient satisfaction — they demonstrate our capability as a trusted partner to biopharma  and healthcare systems looking to deliver better outcomes at scale. From decentralised trials and early access programmes to clinical homecare and real-world data collection, Sciensus enables seamless patient engagement and therapy delivery across the product lifecycle.